Similarly, the nuclear factor of activated T-cells c4 inhibition attenuated metabolic dysfunction-associated steatohepatitis (MASH) by relieving PPARα suppression, enhancing FAO [18]. Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.